Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation

Prostate cancer is a hormone-driven disease and its tumor cell growth highly relies on increased androgen receptor (AR) signaling. Therefore, targeted therapy directed against androgen synthesis or AR activation is broadly used and continually improved. However, a subset of patients eventually progr...

Descripción completa

Detalles Bibliográficos
Autores principales: Merkens, Lina, Sailer, Verena, Lessel, Davor, Janzen, Ella, Greimeier, Sarah, Kirfel, Jutta, Perner, Sven, Pantel, Klaus, Werner, Stefan, von Amsberg, Gunhild
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808994/
https://www.ncbi.nlm.nih.gov/pubmed/35109899
http://dx.doi.org/10.1186/s13046-022-02255-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808994/
https://www.ncbi.nlm.nih.gov/pubmed/35109899
http://dx.doi.org/10.1186/s13046-022-02255-y

Ejemplares similares